


The Fund aims to achieve long-term capital growth through investment in North American securities using a value based investment philosophy.
| Name | % Net Assets | 
|---|---|
| Lincoln National | 2.7% | 
| Merck & Co | 2.6% | 
| Nucor | 2.6% | 
| JP Morgan | 2.6% | 
| Hartford Financial | 2.5% | 
| Morgan Stanley | 2.5% | 
| Wells Fargo | 2.5% | 
| Pfizer | 2.5% | 
| Apache | 2.5% | 
| Cigna | 2.5% | 
| Key | % Net Assets | 
|---|---|
| 2.7% | |
| 2.6% | |
| 2.6% | |
| 2.6% | |
| 89.5% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 199.45p | 
| Currency | GBP | 
| Change | 0.63p | 
| % | 0.32% | 
| YTD change | -2.40p | 
| YTD % | -1.19% | 
| Fund Inception | 01/07/2005 | 
|---|---|
| Fund Manager | Richard Brody | 
| TER | 1.69 (28-Feb-2014) | 
| Minimum Investment | |
|---|---|
| Initial | £500 | 
| Additional | £10 | 
| Savings | £10 | 
| Charges | |
|---|---|
| Initial | 4.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.02 | 
You are here: research